IB Net Payout Yields Model

Invest like me - only at Covestor.com

AMD: Mixed Results Are Good Enough

By -

Following weak numbers from both Intel (INTC) and Nvidia (NVDA), mixed numbers from Advanced Micro Devices (AMD) aren't a huge surprise. The chip company had better than expected Q4 numbers and rather weak Q1 guidance.

  • Q4 sales were lighter-than-expected at $1.42 billion. Analysts polled by Bloomberg were expecting revenue of $1.44 billion during the quarter. 
  • EPS of 8 cents per share which was in-line with consensus estimates.
The key here is that AMD guided to 2019 revenue growth in the high single digit level. The secular trend remains intact and this will rule the stock for the year. My expectation remains that the company will ultimately blow away these numbers making the stock a buy on any dips into the teens.

Analysts are inexplicably down at only 6% revenue growth for the year.  The easy hurdle will help the stock return to the 2018 highs.

More research: AMD: Ramification Of Intel Miss

Update 1/30
The stock is up 10% on a positive view on the share gain opportunity in datacenter. Don't pay attention to these analysts that just don't understand the story in datacenter provides substantial upside to the high single digit growth target.

- JPMorgan raises its AMD target from $18 to $20 on Q4 results that showed the company is “executing well on its product roadmap and making progress toward its 2020 financial model.”

Disclosure: No position. Please review the disclaimer page for more details. 

Comments

Post a Comment

Popular posts from this blog

Occidental: Still Producing Too Much Oil

By -
Image
Though oil continues plunging, the oil giants continue producing more. For Q4, Occidental Petroleum (OXY) had roughly flat production. The worst part is that OXY plans to grow production by 2% to 4% in 2016. The stock has held up somewhat strong, but the inability to turn off the spigot remains troubling. Disclosure: No positions mentioned. Please review the disclaimer page for more details. 
Read more

ChargePoint: Low Quality Beat

By -
Image
  ChargePoint beat FQ2'22 revenue estimates, but the losses are mounting. The company guided up FY22 numbers partly due to acquisitions. The stock still trades at an estimated 21x FY23 number leaving limited upside for the stock and reinforcing why venture funds sold 13.8 million shares. Looking for a portfolio of ideas like this one? Members of Out Fox The Street get exclusive access to our model portfolio.  Learn More » After  solid FQ2'22 earnings ,  ChargePoint Holdings  ( CHPT ) has seen a nice bump in the stock. Now investors have to confront the valuation divide and deal with the past insider sales likely leading to future sales on any stock rallies. My  investment thesis  remains very Bearish on the EV charging station stock on any rallies into the mid-$20s. Read the full article on Seeking Alpha.  Disclosure: No position mentioned. Please review the disclaimer page for more details.  Update - Sept. 8 Be cautious when analysts strugg...
Read more

Aurora Cannabis: Deal Or No Deal

By -
Aurora Cannabis was left out of the major deal making in 2018. The cannabis company updated FQ2 guidance to revenues of $50 to $55 million with a continued focus on pure production growth. The stock is down as the market is becoming less impressed with commodity farming operations due to the prime Oregon example. The stock is below key resistance at $5.40 as medical cannabis patient totals failed to impress. As the end of 2018 came and went,   Aurora Cannabis   ( ACB ) was a notable absentee from the deal making in the cannabis market. Just about all of the other major Canadian cannabis players got large investments or signed up powerful partnerships, but the related stocks didn't generally maintain rallies following the deals. Based on the early legalization data in Canada and Oregon, the best option for Aurora Cannabis might actually be selling production capacity while the Canadian market remains hot. Read the full article on Seeking Alpha.  Disc...
Read more